Cherkasy Regional Oncology Center, Regional Treatment and Diagnostic Hematology Center

Cherkasy 18009

0 studies enrolling now · 2 studies all time

What they study most

B-cell Non-Hodgkin's Lymphoma, DLBCL Transformed From Indolent Lymphoma, Diffuse Large B-Cell Lymphoma, Diffuse Large B-cell Lymphoma, Follicular Grade 3 Lymphoma, de Novo DLBCL

Studies at this site

• Study to Evaluate the Efficacy and Tolerability of Debio 1562 in Combination With Rituximab in Participants With Relapsed and/or Refractory DLBCL and Other Forms of NHL — Completed
• Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant — Completed